Tuesday, September 6, 2016

BRIEF-Walvax Biotechnology to divest stake in Shandong biotech unit

* Says it enters into an agreement to transfer 40 percent

stake and 45 percent stake in its Shandong-based biotechnology

unit to a Shenzhen investment management limited partnership(LP)

and a Yuxi investment management LP respectively

Read more

No comments:

Post a Comment